Premier stockholders approve Patient Square Capital acquisition

Premier Inc. (NASDAQ: PINC) stockholders approved the company's acquisition by Patient Square Capital, with approximately 99% of votes cast supporting the transaction. The approval represents about 79% of Premier's total outstanding shares as of the October 21, 2025 record date.

Under the agreement terms, Premier stockholders will receive $28.25 in cash per share. The company stated this represents a 23.8% premium to Premier's 60-day volume-weighted average price as of September 5, 2025.

The transaction is expected to close on or about November 25, 2025, subject to satisfaction of remaining customary closing conditions. Premier will report the final voting results in a Form 8-K filing with the Securities and Exchange Commission.

Premier describes itself as a technology-driven healthcare improvement company that provides integrated data and analytics, supply chain solutions, and consulting services to healthcare providers, suppliers, and payers. The Charlotte, North Carolina-based company operates collaboratives and other services aimed at healthcare improvement.

Patient Square Capital is identified as a dedicated healthcare investment firm acquiring Premier through an affiliate.

Goldman Sachs and BofA Securities served as financial advisors to Premier, while Wachtell, Lipton, Rosen & Katz provided legal counsel. Patient Square used Kirkland & Ellis as legal counsel and Jefferies and Santander as financial advisors.

The information is based on Premier's press release announcing the stockholder vote results.

You May Also Be Interested In

• LivePerson extends special meeting deadline for SoundHound AI merger vote
• Magna Holdings makes unsolicited bid for 31% of Yatra Online
• Real and RE/MAX Holdings set Aug. 24 merger closing date